We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kevin Emerick MD

Kevin S. Emerick MD

Co-Director, Multi-Disciplinary Cutaneous Oncology Center; Associate Professor of Otolaryngology–Head and Neck Surgery; Associate Program Director, Harvard Otolaryngology Residency Program, Harvard Medical School, Boston, Massachusetts

Kevin S. Emerick, M.D., is an Associate Professor of Otolaryngology, Harvard Medical School and Associate Program Director, Harvard Otolaryngology Residency Program. He is a head and neck surgical oncologist and reconstructive surgeon in the Head and Neck Division at Mass Eye and Ear.  His primary clinical and research interests focus on high risk skin cancers.  He currently co-directs the MEE / MGH Non-Melanoma Skin Cancer Program.  Current research includes identifying drivers of metastasis in cutaneous squamous cell carcinoma and new pathway targets for systemic therapies in cutaneous squamous cell carcinoma as well as defining the role for sentinel lymph node biopsy in non-melanoma skin cancers. From a reconstructive perspective his research clinical research has focused on defining the role of supraclavicular and submental pedicled flaps in head and neck reconstruction.


Dr. Emerick receives honoraria for advisory board for Regeneron.